Literature DB >> 26613645

Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.

L L Ferrari1, L J Agostinelli1, M J Krashes2, B B Lowell3, T E Scammell1, E Arrigoni1.   

Abstract

KEY POINTS: The basal forebrain is an important component of the ascending arousal system and may be a key site through which the orexin neurons promote arousal. It has long been known that orexin-A and -B excite basal forebrain cholinergic neurons, but orexin-producing neurons also make the inhibitory peptide dynorphin. Using whole-cell recordings in brain slices, we found that dynorphin-A directly inhibits basal forebrain cholinergic neurons via κ-opioid receptors, and decreases afferent excitatory synaptic input to these neurons. While the effects of dynorphin-A and orexin-A desensitize over multiple applications, co-application of dynorphin-A and orexin-A produces a sustained response that reverses depending on the membrane potential of basal forebrain cholinergic neurons. At -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at -70 mV the excitatory response to orexin-A prevails. ABSTRACT: The basal forebrain (BF) is an essential component of the ascending arousal systems and may be a key site through which the orexin (also known as hypocretin) neurons drive arousal and promote the maintenance of normal wakefulness. All orexin neurons also make dynorphin, and nearly all brain regions innervated by the orexin neurons express kappa opiate receptors, the main receptor for dynorphin. This is remarkable because orexin excites target neurons including BF neurons, but dynorphin has inhibitory effects. We identified the sources of dynorphin input to the magnocellular preoptic nucleus and substantia innominata (MCPO/SI) in mice and determined the effects of dynorphin-A on MCPO/SI cholinergic neurons using patch-clamp recordings in brain slices. We found that the orexin neurons are the main source of dynorphin input to the MCPO/SI region, and dynorphin-A inhibits MCPO/SI cholinergic neurons through κ-opioid receptors by (1) activation of a G protein-coupled inwardly rectifying potassium current, (2) inhibition of a voltage-gated Ca(2+) current and (3) presynaptic depression of the glutamatergic input to these neurons. The responses both to dynorphin-A and to orexin-A desensitize, but co-application of dynorphin-A and orexin-A produces a sustained response. In addition, the polarity of the response to the co-application depends on the membrane potential of BF neurons; at -40 mV the net effect of the co-application is inhibition by dynorphin-A, whereas at -70 mV the excitatory response to orexin-A prevails. This suggests that depending on their state of activation, BF cholinergic neurons can be excited or inhibited by signals from the orexin neurons.
© 2015 The Authors. The Journal of Physiology © 2015 The Physiological Society.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26613645      PMCID: PMC4753266          DOI: 10.1113/JP271657

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  57 in total

Review 1.  Presynaptic inhibition of glutamate release by neuropeptides: use-dependent synaptic modification.

Authors:  Melanie K Tallent
Journal:  Results Probl Cell Differ       Date:  2008

2.  Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study.

Authors:  A M DePaoli; K M Hurley; K Yasada; T Reisine; G Bell
Journal:  Mol Cell Neurosci       Date:  1994-08       Impact factor: 4.314

3.  Nociceptin/orphanin FQ peptide in hypothalamic neurones associated with the control of feeding behaviour.

Authors:  N Maolood; B Meister
Journal:  J Neuroendocrinol       Date:  2009-12-15       Impact factor: 3.627

4.  Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Authors:  A Crocker; R A España; M Papadopoulou; C B Saper; J Faraco; T Sakurai; M Honda; E Mignot; T E Scammell
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

5.  Vesicular glutamate transporter 1 and vesicular glutamate transporter 2 synapses on cholinergic neurons in the sublenticular gray of the rat basal forebrain: a double-label electron microscopic study.

Authors:  E E Hur; R H Edwards; E Rommer; L Zaborszky
Journal:  Neuroscience       Date:  2009-09-22       Impact factor: 3.590

Review 6.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies.

Authors:  Jim Fadel; Danielle Frederick-Duus
Journal:  Pharmacol Biochem Behav       Date:  2008-01-19       Impact factor: 3.533

7.  Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Authors:  Benjamin B Land; Michael R Bruchas; Selena Schattauer; William J Giardino; Megumi Aita; Daniel Messinger; Thomas S Hnasko; Richard D Palmiter; Charles Chavkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

Review 8.  Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems.

Authors:  Barbara E Jones
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

9.  Neural substrates of awakening probed with optogenetic control of hypocretin neurons.

Authors:  Antoine R Adamantidis; Feng Zhang; Alexander M Aravanis; Karl Deisseroth; Luis de Lecea
Journal:  Nature       Date:  2007-10-17       Impact factor: 49.962

Review 10.  Activation of the basal forebrain by the orexin/hypocretin neurones.

Authors:  E Arrigoni; T Mochizuki; T E Scammell
Journal:  Acta Physiol (Oxf)       Date:  2009-09-01       Impact factor: 6.311

View more
  10 in total

1.  Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

Authors:  Rachel I Anderson; David E Moorman; Howard C Becker
Journal:  Handb Exp Pharmacol       Date:  2018

2.  Melanin-concentrating hormone neurons specifically promote rapid eye movement sleep in mice.

Authors:  Ramalingam Vetrivelan; Dong Kong; Loris L Ferrari; Elda Arrigoni; Joseph C Madara; Sathyajit S Bandaru; Bradford B Lowell; Jun Lu; Clifford B Saper
Journal:  Neuroscience       Date:  2016-09-03       Impact factor: 3.590

Review 3.  Orexin/Hypocretin and Organizing Principles for a Diversity of Wake-Promoting Neurons in the Brain.

Authors:  Cornelia Schöne; Denis Burdakov
Journal:  Curr Top Behav Neurosci       Date:  2017

4.  Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.

Authors:  Alessandra Matzeu; Marsida Kallupi; Olivier George; Paul Schweitzer; Rémi Martin-Fardon
Journal:  Neuropsychopharmacology       Date:  2017-10-20       Impact factor: 7.853

Review 5.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

Review 6.  Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus.

Authors:  Alessandra Matzeu; Rémi Martin-Fardon
Journal:  Front Neurol       Date:  2018-08-28       Impact factor: 4.003

7.  Bulleyaconitine A Inhibits Visceral Nociception and Spinal Synaptic Plasticity through Stimulation of Microglial Release of Dynorphin A.

Authors:  Sheng-Nan Huang; Jinbao Wei; Lan-Ting Huang; Pei-Jun Ju; Jinghong Chen; Yong-Xiang Wang
Journal:  Neural Plast       Date:  2020-05-23       Impact factor: 3.599

8.  Neurochemical Heterogeneity Among Lateral Hypothalamic Hypocretin/Orexin and Melanin-Concentrating Hormone Neurons Identified Through Single-Cell Gene Expression Analysis.

Authors:  Laura E Mickelsen; Fredrick W Kolling; Brock R Chimileski; Akie Fujita; Carol Norris; Kun Chen; Craig E Nelson; Alexander C Jackson
Journal:  eNeuro       Date:  2017-09-22

9.  Galanin neurons in the ventrolateral preoptic area promote sleep and heat loss in mice.

Authors:  Daniel Kroeger; Gianna Absi; Celia Gagliardi; Sathyajit S Bandaru; Joseph C Madara; Loris L Ferrari; Elda Arrigoni; Heike Münzberg; Thomas E Scammell; Clifford B Saper; Ramalingam Vetrivelan
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

Review 10.  The role of co-neurotransmitters in sleep and wake regulation.

Authors:  Jun Oh; Cathrine Petersen; Christine M Walsh; Jackson C Bittencourt; Thomas C Neylan; Lea T Grinberg
Journal:  Mol Psychiatry       Date:  2018-10-30       Impact factor: 15.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.